Another study based on the Breast Cancer Information Management System in Sichuan West China Hospital has also suggested that patients covered by rural schemes (i.e., NRCMS) faced a higher risk of breast cancer-specific mortality (HR: 1.29; 95% CI: 1.00–1.65; P = 0.046) than those covered by urban schemes (URBMI, UEBMI, and/or commercial insurances) when adjusted for age, calendar year at diagnosis, ethnic group, education level, marital status, comorbidity, tumor characteristics (for example, histological type, hormone receptor status, tumor stage) and treatment (23). This evidence concerns the gene NR4A1 and neoplasm.